DekaBank Deutsche Girozentrale’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-32,000
| Closed | -$439K | – | 1261 |
|
|
2019
Q3 | $439K | Sell |
32,000
-32,000
| -50% | -$439K | ﹤0.01% | 787 |
|
|
2019
Q2 | $791K | Buy |
64,000
+19,490
| +44% | +$241K | ﹤0.01% | 830 |
|
|
2019
Q1 | $1.17M | Buy |
44,510
+5,788
| +15% | +$152K | 0.01% | 728 |
|
|
2018
Q4 | $410K | Sell |
38,722
-5,788
| -13% | -$61.3K | ﹤0.01% | 858 |
|
|
2018
Q3 | $1.17M | Buy |
44,510
+2,750
| +7% | +$72.3K | 0.01% | 742 |
|
|
2018
Q2 | $831K | Buy |
41,760
+3,760
| +10% | +$74.8K | 0.01% | 790 |
|
|
2018
Q1 | $676K | Sell |
38,000
-800
| -2% | -$14.2K | ﹤0.01% | 811 |
|
|
2017
Q4 | $621K | Hold |
38,800
| – | – | ﹤0.01% | 783 |
|
|
2017
Q3 | $621K | Hold |
38,800
| – | – | ﹤0.01% | 790 |
|
|
2017
Q2 | $663K | Hold |
38,800
| – | – | 0.01% | 781 |
|
|
2017
Q1 | $512K | Sell |
38,800
-3,300
| -8% | -$43.5K | ﹤0.01% | 735 |
|
|
2016
Q4 | $629K | Buy |
42,100
+3,200
| +8% | +$47.8K | 0.01% | 624 |
|
|
2016
Q3 | $443K | Hold |
38,900
| – | – | ﹤0.01% | 689 |
|
|
2016
Q2 | $412K | Buy |
38,900
+9,100
| +31% | +$96.4K | ﹤0.01% | 712 |
|
|
2016
Q1 | $266K | Sell |
29,800
-5,200
| -15% | -$46.4K | ﹤0.01% | 786 |
|
|
2015
Q4 | $516K | Buy |
35,000
+700
| +2% | +$10.3K | 0.01% | 696 |
|
|
2015
Q3 | $563K | Buy |
34,300
+1,700
| +5% | +$27.9K | 0.01% | 670 |
|
|
2015
Q2 | $744K | Buy |
32,600
+6,800
| +26% | +$155K | 0.01% | 616 |
|
|
2015
Q1 | $392K | Sell |
25,800
-2,300
| -8% | -$34.9K | ﹤0.01% | 775 |
|
|
2014
Q4 | $335K | Sell |
28,100
-3,000
| -10% | -$35.8K | ﹤0.01% | 777 |
|
|
2014
Q3 | $353K | Buy |
31,100
+1,000
| +3% | +$11.4K | ﹤0.01% | 732 |
|
|
2014
Q2 | $364K | Sell |
30,100
-1,500
| -5% | -$18.1K | 0.01% | 669 |
|
|
2014
Q1 | $368K | Buy |
31,600
+1,800
| +6% | +$21K | 0.01% | 629 |
|
|
2013
Q4 | $536K | Buy |
29,800
+800
| +3% | +$14.4K | 0.01% | 534 |
|
|
2013
Q3 | $417K | Buy |
+29,000
| New | +$417K | 0.01% | 573 |
|